Goldshield Group Limited

Goldshield Group Limited, No. 1 Croydon, 12 - 16 Addiscombe Road, Croydon, Surrey, CR0 0XT, UK
Telephone: +44 (0)208 588 9100
Fax: +44 (0)208 686 0807
WWW: http://www.goldshieldgroup.com
Medical Information Direct Line: 08700 70 30 33
Medical Information e-mail: medicalinformation@goldshieldgroup.com
Customer Care direct line: +44 (0)208 588 9273
Medical Information Fax: +44 (0)208 686 0807

Summary of Product Characteristics last updated on the eMC: 27/07/2011
SPC Bupivacaine & Adrenaline Injection BP 0.25% w/v, 1 in 200,000

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 27/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
  • Change to section 4.9 - Overdose
Date of revision of text on the SPC:   04-Jul-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

The mentioned below sections of SPC was amended:

4.8: Undesirable Effects

4.9: Overdose
Updated on 29/04/2011 and displayed until 27/07/2011
Reasons for adding or updating:
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.6 - Pregnancy and Lactation
Date of revision of text on the SPC:   14-Mar-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Following sections of SPC's have been updated:

4.3: Contra-indications

4.4: Special warnings and precautions for use

4.6: Pregnancy and Lactation

 

Updated on 06/08/2009 and displayed until 29/04/2011
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
Date of revision of text on the SPC:  
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

None provided

Active Ingredients/Generics

 
   bupivacaine hydrochloride
   adrenaline acid tartrate